NCT02405598View on ClinicalTrials.gov

Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

June 30, 2016

Conditions
Pompe Disease
Interventions
DRUG

Salbutamol

"1. Albuterol Syrup (1mL= Salbutamol 0.4mg, 60ml/bot)~2. VENTOLIN TABLETS 2MG (SALBUTAMOL SULPHATE)"

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT02405598 - Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease | Biotech Hunter | Biotech Hunter